Table 1:
Patient No. Age/Sex | Tumor Histology | ADC Tumor | ADC Tumor Average | Ratio 1-ROI method | Ratio 3-ROI method |
---|---|---|---|---|---|
1/14 y/M | JPA | 1.45 | 1.44 | 2.02 | 1.93 |
2/7 y/M | JPA | 1.28 | 1.24 | 1.76 | 1.65 |
3/20 mo/M | JPA | 1.64 | 1.66 | 2.18 | 1.90 |
4/11 y/M | JPA | 1.44 | 1.45 | 2.02 | 1.97 |
5/15 y/M | JPA | 1.65 | 1.83 | 2.43 | 2.48 |
6/15 y/F | JPA | 2.01 | 1.97 | 2.93 | 2.70 |
7/6 y/F | JPA | 1.39 | 1.29 | 1.94 | 1.67 |
8/6 y/M | JPA | 1.89 | 1.86 | 2.72 | 2.50 |
9/3 y/M | JPA | 1.44 | 1.48 | 1.62 | 1.77 |
10/21 y/M | JPA | 1.38 | 1.43 | 1.66 | 1.70 |
11/4 y/F | JPA | 1.60 | 1.85 | 2.47 | 2.50 |
12/7 y/M | JPA | 1.62 | 1.60 | 1.84 | 1.90 |
13/6 y/M | JPA | 1.73 | 1.74 | 2.01 | 2.12 |
14/4 y/F | JPA | 1.54 | 1.58 | 2.26 | 2.16 |
15/15 y/F | JPA | 2.09 | 1.93 | 2.99 | 2.76 |
16/7 y/M | JPA | 1.49 | 1.46 | 1.84 | 1.87 |
17/2 y/F | JPA | 2.05 | 2.11 | 2.30 | 2.21 |
18/8 y/M | Ependymoma | 1.08 | 0.97 | 1.28 | 1.15 |
19/16 y/M | Ependymoma | 1.11 | 1.05 | 1.39 | 1.31 |
20/4 y/F | Ependymoma | 1.24 | 1.15 | 1.39 | 1.44 |
21/5 y/F | Ependymoma | 1.07 | 1.05 | 1.43 | 1.42 |
22/22 y/F | Ependymoma | 1.29 | 1.26 | 1.85 | 1.63 |
23/16 y/M | Medulloblastoma | 0.69 | 0.68 | 1.00 | 0.91 |
24/3 y/M | Medulloblastoma | 0.90 | 0.93 | 1.07 | 1.10 |
25/22 y/F | Medulloblastoma | 0.48 | 0.49 | 0.71 | 0.71 |
26/23 y/F | Medulloblastoma | 0.54 | 0.48 | 0.71 | 0.66 |
27/7 y/F | Medulloblastoma | 0.74 | 0.69 | 1.02 | 0.91 |
28/11 y/M | Medulloblastoma | 0.61 | 0.57 | 0.77 | 0.74 |
29/2 y/F | Medulloblastoma | 0.58 | 0.60 | 0.79 | 0.82 |
30/6 wk/M | Medulloblastoma | 0.80 | 0.80 | 0.84 | 0.84 |
31/13 mo/F | AT/RT | 0.60 | 0.63 | 0.69 | 0.74 |
32/15 mo/M | AT/RT | 0.55 | 0.56 | 0.69 | 0.64 |
Note:—1-ROI method indicates the approach wherein a single region of interest of solid enhancing tumor to normal-appearing cerebellum was performed; 3-ROI method, approach used by placing additional regions of interest in the tumor and bilateral centrum semiovale.
ADC values are expressed in 10−3 mm2/s. JPA indicates juvenile pilocytic astrocytoma; AT/RT, atypical teratoid/rhabdoid tumor.